Supplementation with Trp or several microbial Trp metabolites has been demonstrated to protect against colitis in mice through the activation of AhR, followed by the regulation of intestinal barrier, immune response, gut microbiota homeostasis, and other factors (86, 87). The gene discussed is AHR; the disease is colitis.